Morgenstern, A., & Kratochwil, C. (2018). An overview of targeted alpha therapy with 225 Actinium and 213 Bismuth. Current radiopharmaceuticals, 11(3), .
Chicago Style (17th ed.) CitationMorgenstern, Alfred, and Clemens Kratochwil. "An Overview of Targeted Alpha Therapy with 225 Actinium and 213 Bismuth." Current Radiopharmaceuticals 11, no. 3 (2018).
MLA (9th ed.) CitationMorgenstern, Alfred, and Clemens Kratochwil. "An Overview of Targeted Alpha Therapy with 225 Actinium and 213 Bismuth." Current Radiopharmaceuticals, vol. 11, no. 3, 2018.
Warning: These citations may not always be 100% accurate.